Maryam Tehranipour | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Maryam Tehranipour | Pharmacology | Best Researcher Award

Animal Physiology | Islamic Azad University | Iran

Dr. Maryam Tehranipour is an accomplished Associate Professor in the Department of Biology at the Islamic Azad University, Mashhad, Iran, recognized for her distinguished contributions to the fields of diabetes, metabolic disorders, neurobiology, oxidative stress, and cancer biology. Holding a Ph.D. in Animal Physiology, she has built a dynamic academic and research career integrating cellular physiology, pharmacology, and molecular mechanisms of disease. Her extensive publication record spans a broad spectrum of biomedical investigations, including neuroprotective strategies, natural product pharmacology, nanomedicine, and experimental models of diabetes and neurodegeneration. Dr. Tehranipour’s pioneering studies have elucidated the roles of oxidative damage, angiogenesis, and neuronal regeneration in disease progression and therapeutic recovery, particularly highlighting the potential of bioactive compounds and nanocarrier systems in drug design and targeted therapy. Her collaborative work has advanced understanding of diabetic complications, nerve injury repair, and cancer cell modulation through natural and synthetic agents. Beyond her prolific research output, she has played a significant role in mentoring undergraduate, graduate, and doctoral students, fostering scientific rigor and innovation in physiological research. Her scholarly influence is reflected through her indexed publications, contributions to interdisciplinary research networks, and global collaborations that link physiology, biochemistry, and nanotechnology for translational health impact. Dr. Tehranipour’s scientific endeavors emphasize the integration of experimental biology with clinical relevance, aiming to bridge laboratory discoveries with therapeutic applications. Through her ongoing research, she continues to contribute meaningfully to global biomedical science, particularly in developing sustainable and biologically safe therapeutic interventions addressing chronic and degenerative diseases that pose major public health challenges. She has 238 citations from 53 documents with an h-index of 9.

Profile: Scopus 

Publications

1. The Umbelliprenin-CTAB cellulose nanocrystal delivery system prevents hyperglycemia in diabetic rats by activating the insulin receptor IR/PDK1 pathway. (2025). Scientific Reports. Open access.

2. The effects of N-butanol and ethyl acetate fractions of Ferula asafoetida hydroalcoholic extract on the expression of VEGF and FGF genes in the chorioallantoic membrane of chick embryos. (2025). Journal of Veterinary Research.Open access.

3. Bimetallic-based colorimetric aptasensor for the quantitative analysis of ampicillin using catalytic activity of ZrFe metal–organic framework and terminal deoxynucleotidyl transferase-assisted signal amplification. (2025). Bionanoscience. Open access.

4. The effect of Ziziphora clinopodioides hydroalcoholic extract on the neuronal density and histopathology of the hippocampal area CA2 in streptozotocin-induced Alzheimer’s model in male rats. (2025). Journal of Chemical Health Risks. Open access.

5. A novel alpha-terpineol-loaded niosome formulation coated with hyaluronic acid and evaluation of its anticancer properties in vitro. (2025). Journal of Molecular Liquids. Open access.

Maxim Evstigneev | Pharmacology | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Maxim Evstigneev | Pharmacology | Best Researcher Award 

Director | Sevastopol State University | Russia

Dr. Maxim Pavlovich Evstigneev is the Director of the Institute for Advanced Studies at Sevastopol State University, Russian Federation. He earned his Ph.D. and Doctor of Science (DrSci) in Biophysics and was later appointed Full Professor of Physics. Dr. Evstigneev’s research focuses on the thermodynamics of drug interactions, biophysical chemistry, and nanoparticle interactions, with pioneering contributions in understanding DNA-binding drug mechanisms and the biomedical potential of C60 fullerenes. He has authored numerous peer-reviewed journal articles and several scientific books, including DNA-binding Aromatic Drug Molecules: Physico-chemical Interactions and Their Biological Roles and Structure, Thermodynamics and Energetics of Drug-DNA Interactions. His scientific impact is reflected through extensive citations and global recognition. Dr. Evstigneev has received multiple prestigious honors, including awards from the Cabinet of Ministers of Ukraine, the President of Ukraine Award to Young Scientists, and recognition as the youngest Doctor of Sciences in Ukraine. He has also led several national and international research grants supported by major scientific foundations and institutions. Beyond research, he serves as Guest Editor for Organic Chemistry International Journal and was an Editorial Board Member of BioMed Research International. Currently, he is Vice-President of the Crimean Academy of Sciences and a recognized expert for the Russian Academy of Sciences, exemplifying leadership and excellence in molecular biophysics and nanomaterials research. He has 2564 citations from 191 documents with an h-index of 28.

Profiles: Google Scholar | Scopus

Publications

1. The Fundamental Origin of the Polar Contribution to Heat Capacity Changes in Hydration in an Aqueous Solution. (2025). Journal of Physical Organic Chemistry.

2. The Correlated States Theory of the Hydrophobic Effect. (2025). Journal of Physical Chemistry B.

3. Valsartan – Choline: Preparation, Characterization, and Transdermal Permeation. (2025). Journal of Molecular Liquids.

4. Rationalizing DLS Size Distributions of Fullerene Conjugates. (2024). Letter Article.

5.New PMMA-Based Hydroxyapatite/ZnFe₂O₄/ZnO Composite with Antibacterial Performance and Low Toxicity. (2023). Biomimetics.